Bright Minds Biosciences (DRUG) Other financing activities (2020 - 2026)
Bright Minds Biosciences' (DRUG) quarterly Other financing activities came in at $31055.4 in Q1 2026, down 82.18% YoY from $174238.2 in Q1 2025, and up 394.95% on a QoQ basis from $6274.5 in Q4 2025.
Powered by 
Analysis
Bright Minds Biosciences (DRUG) Other financing activities (2020 - 2026) Analysis & Trends
Bright Minds Biosciences (DRUG) has 6 years of Other financing activities data on file, last reported at $31055.4 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Bright Minds Biosciences | 449.62 Mn | 227.08 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 79,232.61 |
| Mar 31, 2026 | 31,055.41 |
| Dec 31, 2025 | 6,274.50 |
| Sep 30, 2025 | 110,448.52 |
| Jun 30, 2025 | 6,314.98 |
| Mar 31, 2025 | 174,238.18 |
| Dec 31, 2024 | 665,801.98 |
| Sep 30, 2024 | -659,748.07 |
| Dec 31, 2023 | 661,081.97 |
| Sep 30, 2023 | -908,170.35 |
| Dec 31, 2022 | 896,935.83 |
| Sep 30, 2022 | 3.00 Mn |
| Dec 31, 2021 | 93,811.99 |
| Sep 30, 2021 | 22.27 Mn |
| Jun 30, 2021 | -19,037.35 |
| Sep 30, 2020 | 732,901.28 |